Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Nancy Moldawer"'
Autor:
Bethany N. Smith, Rajeev Mishra, Sandrine Billet, Veronica R. Placencio-Hickok, Minhyung Kim, Le Zhang, Frank Duong, Anisha Madhav, Kevin Scher, Nancy Moldawer, Amy Oppenheim, Bryan Angara, Sungyong You, Mourad Tighiouart, Edwin M. Posadas, Neil A. Bhowmick
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy. 31(1)
Androgen receptor signaling inhibitors (ARSIs) are standard of care for advanced prostate cancer (PCa) patients. Eventual resistance to ARSIs can include the expression of androgen receptor (AR) splice variant, AR-V7, expression as a recognized means
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d9618b52e7a6f96664d764cf2c26115
https://pubmed.ncbi.nlm.nih.gov/36045587
https://pubmed.ncbi.nlm.nih.gov/36045587
Autor:
Robert A. Figlin, Nancy Moldawer
Publikováno v:
Oncology Nursing Forum. 35:699-708
Purpose/objectives To provide an overview of the current knowledge and treatment options for renal cell carcinoma (RCC). Data sources Published articles, published abstracts, online databases, and package inserts. Data synthesis Researchers have an i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60449b18d2c472fa486477e6c7b58305
https://doi.org/10.1188/08.onf.699-708
https://doi.org/10.1188/08.onf.699-708
Autor:
Allan J. Pantuck, Debby H. Chao, Cho-Lea Tso, Arie S. Belldegrun, Andreas Hinkel, Peter F.A. Mulders, Amnon Zisman, Robert A. Figlin, Barbara J. Gitlitz, Nancy Moldawer
Publikováno v:
Journal of Immunotherapy. 26:412-419
Cultured tumor lysate-loaded dendritic cells (TuLy-DC) have been demonstrated in vitro to stimulate potent immune modulations and generate significant antitumor response. We report the results of a pilot trial of TuLy-DC vaccine for patients with met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::889d289946fdddd56e0d5492bcf1786b
https://doi.org/10.1097/00002371-200309000-00004
https://doi.org/10.1097/00002371-200309000-00004
Autor:
Nancy Moldawer, Ellen Carr
Publikováno v:
American Journal of Nursing. 100:35-40
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96062946cf764b685a1dfdabcbdb4f05
https://doi.org/10.1097/00000446-200005000-00052
https://doi.org/10.1097/00000446-200005000-00052
Autor:
Arie S. Belldegrun, Nancy Moldawer, Barbara J. Gitlitz, William Pierce, Jean B. deKernion, Cho Lea Tso, Randir Kaboo, Robert A. Figlin
Publikováno v:
Journal of Urology. 158:740-745
Purpose: Metastatic renal cell carcinoma is a disease with a mean survival of 6 to 10 months. Interleukin-2 (IL-2), the only approved therapy for metastatic renal cell carcinoma, is associated with a 14% response rate and durable remissions in some p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62389046a1817d7d0c16170364c4775f
https://doi.org/10.1016/s0022-5347(01)64304-0
https://doi.org/10.1016/s0022-5347(01)64304-0
Autor:
Nancy Moldawer, Patricia Creel
Publikováno v:
Oncology nursing forum. 38(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27a68b3846360910c65ce35b0ba092b9
https://pubmed.ncbi.nlm.nih.gov/21356651
https://pubmed.ncbi.nlm.nih.gov/21356651
Autor:
Cho-Lea Tso, Robert A. Figlin, Arie S. Belldegrun, Hungyi Shau, Jean B. deKernion, Patricia Turcillo, Nancy Moldawer, Randhir Kaboo, William Pierce, Sidney H. Golub
Publikováno v:
Journal of Urology. 150:1384-1390
Murine models demonstrate therapeutic synergy for the combination of interleukin-2, interferon-alpha and tumor-infiltrating lymphocytes. We treated 11 patients with metastatic renal cell carcinoma with a novel regimen consisting of in vivo primed tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::982a613da92d19db4676ef42dc7fbe26
https://doi.org/10.1016/s0022-5347(17)35785-3
https://doi.org/10.1016/s0022-5347(17)35785-3
Autor:
Nancy Moldawer, Julia Pfile, Gary R. Jones, Robert P. Whitehead, Jacob Zeffren, Dilip Patel, Robert A. Figlin, Marc L. Citron, Dan Levitt
Publikováno v:
Journal of Immunotherapy. 13:117-121
Interleukin-2 (IL-2) and alpha-interferon have each shown antitumor activity in patients with disseminated malignant melanoma. Because animal studies suggest enhanced activity for the combination over each agent used alone, this trial using a relativ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26d788a96eebba1c28d298e563617f1b
https://doi.org/10.1097/00002371-199302000-00006
https://doi.org/10.1097/00002371-199302000-00006
Autor:
Allan J. Pantuck, Robert A. Figlin, Nancy Moldawer, Robert M. Strieter, Arie S. Belldegrun, Marie D. Burdick, Karen L. Reckamp
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 30(4)
Chemokines play an important role in regulating tumor-mediated immunity, angiogenesis, and tumor cell metastasis. The chemokine receptor, CXCR3, is expressed in various human tumors, including renal cell carcinoma (RCC). CXCR3 is also associated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1130bc8d7d78802aa7c6eafd409ffc5d
https://pubmed.ncbi.nlm.nih.gov/17457216
https://pubmed.ncbi.nlm.nih.gov/17457216
Autor:
Frances Rosen, Nancy Moldawer, Robert A. Figlin, Barbara J. Gitlitz, Sylvia M. Kiertscher, Michael D. Roth
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 26(2)
Antigen-presenting cells (APC), such as dendritic cells (DC), are the key component of many cancer immunotherapy strategies. However, DCs comprise a rare population of clinically obtainable cells and are compromised in function in cancer-bearing host
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8cf2e05b3f0a3673431dec3b1058047
https://pubmed.ncbi.nlm.nih.gov/12616109
https://pubmed.ncbi.nlm.nih.gov/12616109